BioInvest.com Blog

Welcome to the BioInvest.com blog. Contact us with any comments, questions, suggestions or tips. Subscribe to our RSS.

Recent Posts:

Sponsored Links
Powered by Squarespace
Medical Technology Stock Letter

BioInvest.com is the web home of the Medical Technology Stock Letter, an industry leading newsletter covering the biotech sector for almost thirty years.  Seeking information on FDA Approvals, Biotech Mergers & Acquisitions, Stock Picks, Long Investments and the occassional Short Sale?  Trying to stay on the cutting edge of scientific developments so you can stay ahead of the Markets? 

The Medical Technology Stock Letter is the source for Biotechnology news and investing advice.  Forget the pundits and the trends.  Here you find only experienced insight and the details that Wall Street doesn't want you to know.

Request a Free Issue then go to the Newsletter page to find out what's new at MTSL.

Subscribers, click here to log in or go directly to the Subscriber area.

Search BioInvest.com
Loading
Latest News from Yahoo! Finance
« FDA panel turns down Vivus' diet drug | Main

New BioInvest.com coming soon

Welcome to BioInvest.com, the web home of the Medical Technology Stock Letter.  Please check back soon for updates. 

PrintView Printer Friendly Version

EmailEmail Article to Friend

References (2)

References allow you to track sources for this article, as well as articles that were written in response to this article.

Reader Comments (2)

test comment

June 17, 2010 | Unregistered CommenterJerry

This is a comment made June 24th

June 25, 2010 | Registered CommenterAdministrator
Member Account Required
You must have a member account on this website in order to post comments. Use the Navigation bar to the left to log in to your account or register.